Person

Scott T. Reents

EVP, CHIEF FINANCIAL OFFICER, AbbVie

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$8.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • ABBV
    AbbVie
    EVP, CHIEF FINANCIAL OFFICER
    since Jul 2022

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 14, 2025ABBVSale17,644$212.34$3.7M
Feb 23, 2024ABBVSale14,140$177.44$2.5M
Mar 1, 2023ABBVSale850$153.38$130K
Mar 1, 2023ABBVSale15,092$153.06$2.3M

SEC reporting-owner ID (CIK) 1937048 · all filings on EDGAR